MPLT — MapLight Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapNeutral

Annual balance sheet for MapLight Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27.7	79.8	109
Prepaid Expenses
Total Current Assets	32	83.6	115
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.12	6.58	7.56
Long Term Investments
Other Long Term Assets
Total Assets	39.4	91.4	137
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	12.6	14.7	15.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	18.5	20.1	21.7
Redeemable Preferred Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	20.9	71.3	115
Total Liabilities & Shareholders' Equity	39.4	91.4	137
Total Common Shares Outstanding